FDA Seeks Input on Teen Tobacco Snooping Survey Renewal
Published Date: 5/4/2026
Notice
Summary
The FDA wants your thoughts on continuing the National Youth Tobacco Survey, which checks how many young people use tobacco. This survey helps protect kids and teens by tracking tobacco habits and making smarter health rules. If you want to share your opinion, send your comments by July 6, 2026—no cost to you, just your voice!
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Parents May Need to Return Consent Forms
If your child is in grades 6–12, parents or guardians may need to complete an active consent form for the National Youth Tobacco Survey. FDA estimates 3,500 parents will be asked to spend about 10 minutes each (total 595 hours) to return these forms for the 2027–2029 survey period.
Students Will Take a 45-Minute Digital Survey
Students in grades 6–12 will be asked to take an anonymous, web-based tobacco survey that takes about 45 minutes. FDA estimates 29,575 student questionnaire responses for 2027–2029, totaling about 22,181 hours of student response time.
Overall Respondent Burden Will Rise
For the 2027–2029 NYTS, FDA estimates the overall respondent burden increases by 1,108 hours and 4,313 responses compared with the prior period. FDA reports a total annual burden of 23,708 hours across all respondent types for this information collection.
No Direct Money Costs to Respondents
FDA states there are no capital costs or operating and maintenance costs associated with this information collection, so respondents will not face direct monetary charges. You are asked only to provide information or return consent forms by the July 6, 2026 comment date if you want to comment on the collection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
Previous / Next Documents
Previous: 2026-08602 — Investigative Hearing
A tragic UPS cargo plane crash in Louisville killed 14 people and injured many more, sparking a big public hearing on May 19-20, 2026. The hearing will dig into airplane safety, design rules, and how the FAA and Boeing handle safety issues. This affects airlines, manufacturers, and passengers, aiming to boost safety and prevent future accidents.
Next: 2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve new costs or changes to the process.